RYTM EBITDA Growth
Rhythm Pharmaceuticals Inc · EBITDA Growth
RYTM EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-15.71%period ending
RYTM TTM EBITDA YoY % (-445183.33% → -15.71%)
Year-over-year change
High-resolution chart · PNG
RYTM ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -15.7127% | |
| -23.5291% | |
| 27.0273% | |
| 28.8407% | |
| 33.3117% | |
| 42.7398% | |
| -41.7831% | |
| -39.0172% | |
| -41.6973% | |
| -49.8853% | |
| 3.4164% | |
| 8.0076% | |
| 11.6676% | |
| 8.7419% | |
| -3.3439% | |
| -21.4175% | |
| -33.4617% | |
| -38.4412% | |
| -24.0814% | |
| -13.294% | |
| -3.9695% | |
| 10.0484% | |
| 6.3934% | |
| 2.2069% | |
| -14.577% | |
| -64.3018% | |
| -86.1699% | |
| -122.8337% | |
| -135.6172% | |
| -113.371% | |
| -142.2411% | |
| -109.4268% | |
| -84.3105% | |
| -60.2471% | |
| -58.0682% | |
| -145.6493% | |
| -386.0502% | |
| -445,183.3333% |